Legal Representation
Attorney
Jessica L. Rothstein
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 14, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 14, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 14, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 14, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 14, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 14, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 19, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jun 19, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Dec 18, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 18, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 18, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 18, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 18, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 18, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 5, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 5, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Aug 5, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 5, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jul 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 1, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 1, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 1, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 1, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 4, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 4, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 16, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Sep 16, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in the fields of oncology, rare diseases, and genetically defined diseases
Class 042
Development of pharmaceutical preparations and medicines; Scientific research and development; Pharmaceutical research and development services; Clinical research for others in the fields of oncology, rare diseases, and genetically defined diseases; Medical and scientific research, namely, conducting clinical trials for others
Additional Information
Design Mark
The mark consists of the word COGENT above a smaller word BIOSCIENCES, with swirling dots encircling the C and the O in COGENT.
Design Mark
The mark consists of the word COGENT above a smaller word BIOSCIENCES, with swirling dots encircling the C and the O in COGENT.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"
Specific Disclaimer
"BIOSCIENCES"